| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
3 companies
Schenkein David P is a Director at AGIOS PHARMACEUTICALS, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 21 sells.
Estimated insider holdings value: $5.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | DNLI Denali Therapeutics Inc. | Director | Sell | 30,000 | $90.05 | $2,701,582.00 | -53.4% | |
| Nov 12, 2020 | DNLI Denali Therapeutics Inc. | Director | Sell | 30,000 | $70.05 | $2,101,590.00 | -54.5% | |
| Nov 10, 2020 | DNLI Denali Therapeutics Inc. | Director | Sell | 10,000 | $60.03 | $600,310.00 | -15.4% | |
| Nov 4, 2020 | DNLI Denali Therapeutics Inc. | Director | Sell | 10,000 | $50.18 | $501,830.00 | -13.3% | |
| Nov 13, 2019 | AGIO Agios Pharmaceuticals, Inc. | Director | Buy | 8,064 | $31.00 | $249,984.00 | +9.0% | |
| Jun 1, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 13,000 | $95.35 | $1,239,607.70 | -46.6% | |
| May 30, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 45,626 | $90.07 | $4,109,533.82 | -100% | |
| May 23, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 49,374 | $90.40 | $4,463,523.71 | -83.3% | |
| May 1, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 13,000 | $83.04 | $1,079,500.52 | -81.2% | |
| Apr 2, 2018 | AGIO Agios Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 13,000 | $77.72 | $1,010,356.65 | -31.8% |